AIIMS Delhi: second dose trial of Covaxin on 2-6 years old children to take place

AIIMS in New Delhi will commence the second dose trial of Bharat Biotech’s COVID-19 vaccine, Covaxin, for children aged 2-6 years.

As per the current records, the first trial was done on the children aged between 2-6 years of Bharat Biotech Covaxin after the successful response the center has decided for the second jab trial will commence from next week.

AIIMS Delhi is recorded as one of the trial centers for vaccinating children below the age of 18 years, sources also added that the second jab of Covaxin has already been administered to children in the age group of 6-12 years at AIIMS, Delhi.

As per ANI news sources, the first trial was started for the age group of 12-18 years followed by the age group of 6-12 years and 2-6 years which are undergoing trials currently.

Besides this, it was also noticed recently that the Centre informed the Delhi High Court about the clinical trials of COVID-19 vaccines for children under 18 years of age were to get completed soon.

Amid this, the government officials also informed the Supreme Court earlier that,  Zydus Cadila’s DNA vaccine has concluded its clinical trial for the age group of 12 to 18.

The center added a statement which stated that “It is submitted that Zydus Cadila, which is developing DNA vaccines has concluded its clinical trial for between the age group of 12 to 18 and subject to the statutory permissions, the same may be available in near future for children of the age group of 12 to 18 years of age.”

It also added besides it, it has been achieving 100 percent vaccination in the shortest time possible is the Centre’s topmost priority and all efforts are being made to achieve it.

Subscribe to our newsletter
Subscribe to our newsletter
Sign up here to get the latest news delivered directly to your inbox.
You can unsubscribe at any time